Form D · Other Health Care

ReEngage Therapeutics, Inc.

Houston, TX · CIK 0002022524

Offering snapshot reported Jul 1, 2025 · SEC filing

Reported sold
$365K
Offering amount: $8M
Investors reported
6
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jun 10, 2025
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$183K$365KJun 18, 2025: $250,000.00Jun 18, 2025Jul 1, 2025: $365,000.00Jul 1, 2025

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$250,000 → $365,000
  • Reported investors1 → 6

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 1, 2025Amendment$365,000$115,000vs Jun 18, 20256SEC filing
Jun 18, 2025Initial$250,000No comparison1SEC filing
Dec 16, 2024Initial$65,000No comparison5SEC filing

Offering details

Securities
Debt, Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-549288

Source: Form D, filed Jul 1, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Thomas Kim Director, Executive

Issuer details

Industry: Other Health Care (See others in industry)

Address:
2450 Holcombe Blvd. Suite 1200
Houston, TX, 77021